Blackstone’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-4,544
Closed -$264K – 634
2026
Q1
$264K Buy
+4,544
New +$247K ﹤0.01% 372

Other funds holding PCVX

Blackstone's PCVX Position: Q2 2026 in Review

Blackstone sold out of Vaxcyte (PCVX) in Q2 2026, closing a stake of 4,544 shares — an estimated $264K sold.

Blackstone first reported a position in PCVX in Q1 2026 and held it in 1 quarter. The position peaked at $264K in Q1 2026. 333 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Blackstone reported no remaining Vaxcyte position as of Q2 2026 after selling out during the quarter.
  • Blackstone sold 4,544 Vaxcyte shares in Q2 2026, an estimated $264K.
  • Blackstone first reported a position in Vaxcyte in Q1 2026 and held it in 1 quarter.
  • Blackstone's Vaxcyte position peaked at $264K in Q1 2026.
  • 333 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.